Welcome to the Holistic Wellness Center of the Carolinas – Research Based Functional Wellness

Autoimmune skin conditions such as eczema and psoriasis can be challenging to manage. Traditional treatments often focus on managing symptoms rather than addressing the root cause of the condition. IV therapy with glutathione, zinc, selenium, and NAD can help manage autoimmune skin conditions by reducing inflammation and supporting the immune system.

Glutathione is a powerful antioxidant that can help reduce oxidative stress in the body. It also plays a crucial role in regulating the immune system and reducing inflammation. Zinc and selenium are essential minerals that are required for optimal immune system function. Deficiencies in these minerals have been linked to autoimmune skin conditions.

NAD, or nicotinamide adenine dinucleotide, is a coenzyme that is involved in many cellular processes, including energy production and DNA repair. It has been shown to have anti-inflammatory effects and can help regulate the immune system. NAD levels can be depleted in individuals with autoimmune conditions, and IV therapy can help restore optimal levels.

The mechanism of action behind IV therapy with glutathione, zinc, selenium, and NAD involves reducing inflammation and supporting the immune system. Autoimmune skin conditions are characterized by an overactive immune response, leading to inflammation and damage to the skin. IV therapy can help regulate the immune system, reducing inflammation and promoting healing of the skin.

Sources:

• Famenini, S., & Gelfand, J. M. (2015). Role of the microbiome in psoriasis: moving from disease description to treatment prediction?. Journal of investigative dermatology, 135(9), 2125-2131.
• Guo, Y., Zhang, Y., Gerhard, R., Du, H., & Lü, J. (2020). The role of oxidative stress in psoriasis. Oxidative medicine and cellular longevity, 2020.
• El Gendy, A. M., Aly, D. G., Alqutub, M. N., & Algaidi, S. A. (2020). A Review of the Role of Micronutrients in Autoimmune Skin Diseases. Dermatology and therapy, 10(5), 809-824.
• Micera, A., Vezzani, S., Alessandrini, F., & Bonini, S. (2019). Pharmacological modulation of NAD+ levels: therapeutic potential for age-related and autoimmune diseases. Frontiers in immunology, 10, 2247.